NEW YORK (GenomeWeb) – MDxHealth announced today that it has partnered with the Andros Men's Health Clinic in the Netherlands to offer its SelectMDx liquid biopsy prostate cancer test to Andros' patients.

Under the terms of the deal, the clinic will offer the diagnostic to all patients considered at risk for prostate cancer, with over 500 patients to undergo testing in the first year of the partnership. SelectMDx will become available starting April 1.

Further terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.